Feedback / Questions
MesoPher (autologous dendritic cell vaccine) - Erasmus MC, Amphera
https://www.businesswire.com/news/home/20220801005324/en/Last-patient-completed-follow-up-period-in-Phase-IIIII-study-of-Amphera%E2%80%99s-MesoPher-cell-therapy-in-mesothelioma
Aug 1, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next